Keywords: وضعیت عملکرد; Acute myeloid leukemia; Allogeneic transplantation; Myelodysplastic syndromes; Performance status; Prognosis; Therapy;
مقالات ISI وضعیت عملکرد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: وضعیت عملکرد; Severity of pneumonia; Drug-resistant bacteria; Performance status; Healthcare-associated pneumonia; Nursing and healthcare-associated pneumonia;
Keywords: وضعیت عملکرد; Performance status; Intensive care; Hospital mortality; Prognosis
Role of radiotherapy in patients with limited diffuse large B-cell lymphoma of Waldeyer's ring in remission after R-CHOP immunochemotherapy
Keywords: وضعیت عملکرد; WR; Waldeyer's ring; NHL; non-Hodgkin's lymphoma; DLBCL; diffuse large B-cell lymphoma; RT; radiotherapy; IFRT; Involved field radiation therapy; CT; immunochemotherapy; PET-CT; positron emission tomography-computed tomography; DFS; disease free survi
ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease
Keywords: وضعیت عملکرد; ILD; interstitial lung disease; NSCLC; non-small cell lung cancer; AE; acute exacerbation; IPF; idiopathic pulmonary fibrosis; %FVC; percent predicted forced vital capacity; %DLCO; percent predicted diffusion capacity of lung for carbon monoxide; TKI; tyr
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)
Keywords: وضعیت عملکرد; Modified Glasgow Prognostic Score; Recurrent ovarian cancer; Health related quality of life; Performance status; Prognostication;
Factors associated with gene aberration test status and treatment decision in patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer: A multicenter survey in China (CTONG 1506)
Keywords: وضعیت عملکرد; ALK; anaplastic lymphoma kinase; CI; confidence interval; CTONG; Chinese Thoracic Oncology Group; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; MERAF; Medical Record Abstraction Form; NSCLC; non-small cell lung cancer;
Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era
Keywords: وضعیت عملکرد; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; IQR; interquartile range; HR; hazard ratio; AHR; adjusted hazard ratio; CTP; Child-Turcotte-Pugh; PS; performance status; ECOG; Eastern Cooperative Oncology Group; BCLC; Barcelona Clinic Liver Cancer;
Analysis of CTLA-4Â +Â 49A/G gene polymorphism in cases with leprosy of Azerbaijan, Northwest Iran
Keywords: وضعیت عملکرد; Leprosy; CTLA-4; Gene polymorphism; T-ARMS-PCR; Age at the disease onset; Performance status;
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer
Keywords: وضعیت عملکرد; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; body surface area; Ccr; creatinine clearance; CI; confidence interval; CR; complete response; CTCAE; common terminology criteria for adverse events; DCR;
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
Keywords: وضعیت عملکرد; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; AE-ILD; acute exacerbation of interstitial lung disease; NSCLC; non-small cell lung cancer; S-1; tegafur-gimeracil-oteracil potassium; CBDCA; carboplatin; RECIST;
Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder
Keywords: وضعیت عملکرد; Bladder cancer; Cisplatin; Cystectomy; Pathologic response; Performance status;
Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer
Keywords: وضعیت عملکرد; NSCLC; non-small cell lung cancer; LVI; lymphovascular invasion; ACT; adjuvant chemotherapy; OS; overall survival; RFS; recurrence-free survival; CT; computed tomography; VPI; visceral pleura invasion; PET/CT; positron emission computerized tomography and
Effect of chest tube position on the success rate of pleurodesis: A retrospective cohort study
Keywords: وضعیت عملکرد; IRB; institutional review board; CT; computed tomography; LD; lactate dehydrogenase; PS; performance status; STROBE; strengthening the reporting of observational studies in epidemiology; Malignant pleural effusion; Minocycline; OK-432; Pleurodesis; Talc;
Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas® EGFR mutation test
Keywords: وضعیت عملکرد; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; EGFRm; EGFR mutation-positive; FFPE; formalin-fixed, paraffin-embedded; NSCLC; non-small cell lung cancer; PD; progressive disease; PS; performance status; SD; standard devi
Research paperA randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14)
Keywords: وضعیت عملکرد; AUC; area under the curve; IPC; indwelling pleural catheter; LOS; length of stay; MBS; modified Borg scale; MPE; malignant pleural effusion; NVALT; Dutch society of pulmonologists; PRO; patient reported outcome; PS; performance status; QoL; quality of lif
Les patients avec indice de performance supérieur à 1
Keywords: وضعیت عملکرد; Indice de performance; Néoplasmes pulmonaires; Chimiothérapie; Immunothérapie; Agents ciblés; Performance status; Lung neoplasms; Chemotherapy; Immunotherapy; Targeted agents;
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1
Keywords: وضعیت عملکرد; LC; lung cancer; ILD; interstitial lung disease; HRCT; high-resolution computed tomography; AE; acute exacerbation; DAD; diffuse alveolar damage; IPF; idiopathic pulmonary fibrosis; PS; performance status; ECOG; Eastern Cooperative Oncology Group; NSCLC;
Original ResearchRamucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study
Keywords: وضعیت عملکرد; Ramucirumab; Sorafenib; Hepatocellular carcinoma; Patient-focused outcomes; Quality of life; Performance status;
Brief ReportAnxiety After Diagnosis Predicts Lung Cancer-Specific and Overall Survival in Patients With Stage III Non-Small Cell Lung Cancer: A Population-Based Cohort Study
Keywords: وضعیت عملکرد; Anxiety; depression; distress; performance status; lung cancer; mortality;
Clinical outcomes and prognostic factors in gastric cancer patients aged â¥85 years undergoing endoscopic submucosal dissection
Keywords: وضعیت عملکرد; ASA-PS; American Society of Anesthesiologists Performance Status; BMI; body mass index; CCI; Charlson comorbidity index; CI; confidence interval; DFS; disease-free survival; ECOG-PS; Eastern Cooperative Oncology Group Performance Status; EGC; early gastri
Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis
Keywords: وضعیت عملکرد; Geriatric oncologic; Nonagenarians; Octogenarians; Performance status; Radiation pneumonitis;
Life after hyperthermic intraperitoneal chemotherapy; measuring quality of life and performance status after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
Keywords: وضعیت عملکرد; Cytoreductive surgery; Hyperthermic intraperitoneal chemoptherapy; Quality of life; Performance status
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer
Keywords: وضعیت عملکرد; EGFR; epidermal growth factor receptor; TKIs; tyrosine-kinase inhibitors; NSCLC; non-small-cell lung cancer; PFS; progression-free survival; FISH; fluorescence in-situ hybridization; IHC; immunohistochemistry; ERCC1; excision repair cross-complementation
A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy
Keywords: وضعیت عملکرد; AE; adverse event; CI; confidence interval; CR; complete response; CT; computed tomography; DCR; disease control rate; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; FAS; full analysis set; HR; hazard ratio; ILD; interst
Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer
Keywords: وضعیت عملکرد; Charlson comorbidity index; Chemotherapy; Comorbidity; Lung cancer; Performance status; Simplified comorbidity score; Survival;
Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications
Keywords: وضعیت عملکرد; Denver shunt; Malignant ascites; Performance status; Peritoneal catheter; Teneckoff catheter;
Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer
Keywords: وضعیت عملکرد; EGFR mutation-negative; Non-squamous non-small-cell lung cancer; Erlotinib; Pemetrexed; Docetaxel; Performance status; Second-line treatment;
Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC)
Keywords: وضعیت عملکرد; Cis; cisplatin; CT; chemotherapy; ECOG; Eastern Cooperative Oncology Group; ESMO; European Society for Medical Oncology; G; grade; GTV; gross tumor volume; CTV; clinical target volume; Pem; pemetrexed; PS; performance status; PTV; planning target volume;
Maintenance chemotherapy in advanced NSCLC: A population-based assessment of eligibility
Keywords: وضعیت عملکرد; Maintenance chemotherapy; NSCLC; Performance status; Response; Second line; Population based
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status
Keywords: وضعیت عملکرد; Capecitabine; Elderly; FOLFOX; Gastric cancer; Performance status
Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301)
Keywords: وضعیت عملکرد; NSCLC; Elderly; Gefitinib; Docetaxel; Gemcitabine; Performance status;
Yttrium-90 Glass-Based Microsphere Radioembolization in the Treatment of Hepatocellular Carcinoma Secondary to the Hepatitis B Virus: Safety, Efficacy, and Survival
Keywords: وضعیت عملکرد; AFP; α-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; ECOG; Eastern Cooperative Oncology Group; HBV; hepatitis B virus; HBV-HCC; hepatocellular carcinoma resulting from hepatitis B virus etiology; HCC; hepatocellular carcinoma
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis
Keywords: وضعیت عملکرد; NSCLC; Chemotherapy; Performance status; Platinum; Doublet; Single agent
Research ArticleEarly dermatologic adverse events predict better outcome in HCC patients treated with sorafenib
Keywords: وضعیت عملکرد; OS; Overall survival; HCC; Hepatocellular carcinoma; AE; adverse events; PS; Performance status; BCLC; Barcelona Clinic Liver Cancer classification; TTP; Time to progression; AASLD; American Association for the Study of Liver Disease; AE60; AE with in the
Patients over 65Â years are assigned lower ECOG PS scores than younger patients, although objectively measured physical activity is no different
Keywords: وضعیت عملکرد; Eastern Co-operative Oncology Group; Performance status; Physical activity; Accelerometer; Geriatric assessment;
Trimodality Therapy for Superior Sulcus Non-Small Cell Lung Cancer: Southwest Oncology Group-Intergroup Trial S0220
Keywords: وضعیت عملکرد; ARDS; adult respiratory distress syndrome; BID; twice per day; CDDP; cisplatin; Chem Rx; chemotherapy; CI; confidence interval; csf; cerebrospinal fluid; CT; computed tomography; CTCAE; Common Terminology Criteria for Adverse Events; DFS; disease-free sur
Outcomes for Patients With Cancer Admitted to the ICU Requiring Ventilatory Support
Keywords: وضعیت عملکرد; ARF; acute respiratory failure; MV; mechanical ventilation; NIV; noninvasive ventilation; PS; performance status; SAPS 3; Simplified Acute Physiology Score (third version); SOFA; Sequential Organ Failure Assessment;
Percutaneous Microwave Ablation of Hepatic Tumors: Prospective Evaluation of Postablation Syndrome and Postprocedural Pain
Keywords: وضعیت عملکرد; ALT; alanine aminotransferase; AST; aspartate aminotransferase; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; IQR; interquartile range; i.v.; intravenous; OR; odds ratio; PAS; postablation syndrome; PS; performance status; RF; r
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial
Keywords: وضعیت عملکرد; Aflibercept; VEGF Trap; Bevacizumab; Metastatic colorectal cancer; Performance status; Subgroup analysis;
Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
Keywords: وضعیت عملکرد; TACE; Overall Survival; Outcome; Prediction Model; BCLC; Barcelona Clinic Liver Cancer; CART; classification and regression tree; ECOG; Eastern Cooperative Oncology Group; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HKLC
Research ArticleGemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study
Keywords: وضعیت عملکرد; HCC; hepatocellular carcinoma; OS; overall survival; AFP; α-fetoprotein; TACE; transarterial chemoembolization; TTP; time to progression; PFS; progression-free survival; PS; performance status; CLIP; Cancer of the Liver Italian Program; ORR; overall resp
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601
Keywords: وضعیت عملکرد; CRC; colorectal cancer; FU; fluorouracil; LV; leucovorin; OS; overall survival; PFS; progression-free survival; pi; protracted infusion; PS; performance status; HR; hazard ratio; Colorectal cancer; Metastases; Primary tumour resection; Multivariate analys
Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes
Keywords: وضعیت عملکرد; Geriatric assessment; Leukemia; Acute; Myeloid; Prognosis; Performance status; Comorbidity
The pathological confirmation rate of lung cancer in England using the NLCA database
Keywords: وضعیت عملکرد; Lung cancer; Histology; Cytology; Pathology; Survival; Performance status
Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials
Keywords: وضعیت عملکرد; Urothelial carcinoma; Second line; Prognosis; Time from prior chemotherapy; Hemoglobin; Liver metastasis; Performance status
A phase II trial of frontline capecitabine and bevacizumab in poor performance status and/or elderly patients with metastatic colorectal cancer
Keywords: وضعیت عملکرد; Colon cancer; Colorectal cancer; Elderly; Frail; Chemotherapy; Metastatic; Toxicity; Efficacy; Response rate; Survival; Performance status
Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis
Keywords: وضعیت عملکرد; CTCAE; Common Terminology Criteria for Adverse Events; EASL; European Association for the Study of the Liver; ECOG; Eastern Cooperative Oncology Group; ICC; intrahepatic cholangiocarcinoma; OS; overall survival; PS; performance status; RECIST; Response Ev
Multivariate Analysis of Prognostic Factors for Survival following Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
Keywords: وضعیت عملکرد; AFP; α-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CTP; Child-Turcotte-Pugh; DEB; doxorubicin-eluting bead; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; HR; hazard ratio; INR; International N
Factors Affecting Survival following Chemoembolization with Doxorubicin-eluting Microspheres for Inoperable Hepatocellular Carcinoma
Keywords: وضعیت عملکرد; AFP; α-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; CLIP; Cancer of the Liver Italian Program; DEB; drug-eluting bead; EASL; European Association for the Study of the Liver; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; OS